Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
Ontology highlight
SUBMITTER: Faivre-Finn C
PROVIDER: S-EPMC5555437 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA